Volume 3.17 | May 5

Cord Blood News 3.17, May 5, 2011
     In this issue: Science News | Current Publications | Industry News | Policy News | Events
Cell Therapy News on Facebook  Cord Blood News on Twitter
TOP STORY

Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Improve Glucose Homeostasis in Rats with Liver Cirrhosis
Researchers investigated whether umbilical cord blood-derived mesenchymal stem cells have an effect on the expression of molecules responsible for glucose utilization and hepatic gluconeogenesis, focusing on the insulin signaling pathway in rats with liver cirrhosis. [Int J Oncol]

STEMSOFTStemLab_645x110_gif

CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)

Pomalidomide Augments Fetal Hemoglobin Production without the Myelosuppressive Effects of Hydroxyurea in Transgenic Sickle Cell Mice
Researchers investigated the effects of pomalidomide on erythropoiesis and hemoglobin synthesis in a transgenic mouse model of sickle cell disease. [Blood]

Endothelial Fate and Angiogenic Properties of Human CD34+ Progenitor Cells in Zebrafish
In the present study, human cord blood–derived CD34+ cells were transplanted into pre- and postgastrulation zebrafish embryos and in an adult vascular regeneration model induced by caudal fin amputation. [Arterioscler Thromb Vasc Biol]

Optimal Conditions for Lentiviral Transduction of Engrafting Human CD34+ Cells
Researchers sought to optimize transduction and engraftment of human CD34+ cells using lentiviral vectors. [Gene Ther]

A Comparison of Methods for Quantifying Angiogenesis in the Matrigel Assay In Vitro
Here, researchers have measured the ability of umbilical cord blood endothelial colony forming cell derived cells to form tubules in Growth Factor Reduced Matrigel in the presence or absence of two angiogenic inhibitors, suramin and SU6668, in order to compare the benefits and limitations of two quantification methods – Angiosys and Wimasis. [Tissue Eng Part C Methods]

Estradiol and Progesterone Strongly Inhibit the Innate Immune Response of Newborn Mononuclear Cells
Here researchers show that, at concentrations present in umbilical cord blood, estradiol and progesterone are as powerful as hydrocortisone to inhibit cytokine production by cord blood mononuclear cells and newborn monocytes. [Infect Immun]

The CYP4A/F-20-HETE System in Regulation of Endothelial Precursor Cell Derived from Human Umbilical Cord Blood
Researchers studied whether angiogenic effects of the CYP4A/F-20-HETE system involves regulation of endothelial precursor cell (EPC) function. They isolated EPC from human umbilical cord blood. [J Pharmacol Exp Ther]

Xenogeneic Immunosuppression of Human Umbilical Cord Mesenchymal Stem Cells in a Major Histocompatibility Complex (MHC)-Mismatched Allogeneic Acute Graft-versus-Host Disease Murine Model
In this study, researchers investigated the influence of xenogeneic human umbilical cord mesenchymal stem cells on acute graft-versus-host-disease in murine allogenic bone marrow transplantation. [Eur J Haematol]

The Mixed Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Show Higher Antitumor Effect Against C6 Cells than the Single In Vitro
The data collected herein confirm for the first time that the mixed umbilical cord blood mesenchymal stem cells (UCB-MSCs) were shown to have more cytotoxic effects than the single UCB-MSCs through increasing the expression of caspase-3 and decreasing the expression of CD133 in C6 glioma cells. [Neurol Res]

Quality Assessment of Umbilical Cord Blood Units at the Time of Transplantation
The aim of this study was to compare the umbilical cord blood (UCB) characteristics analyzed at the site of infusion of the UCB with those provided by cord blood banks (CBBs). [Int J Hematol]


 
 
Need to expand CD34+ cells?
StemSpan® serum-free expansion media are optimized for expanding hematopoietic stem and progenitor cells
 
 
DOWNLOAD THE TECHNICAL BULLETIN STEMCELL Technologies Inc
   
 

INDUSTRY NEWS

Cryo-Cell Announces Advanced New Service and Exclusive Family Healthcare Protection Plan
Cryo-Cell International, Inc., one of the world’s largest and most established family cord blood banks and global stem cell innovators,
announced its plans at the American College of Obstetrics and Gynecology annual meeting to launch an advanced new service named U-Cord Plus®, along with an exclusive family healthcare protection plan named P3 Protect Baby, Protect Mom, Protect Family®. [Cryo-Cell International, Inc. Press Release]


Nearly 30 Percent of New CIRM Awards go to UC San Diego Stem Cell Researchers
UC San Diego scientists garnered 8 of the total 27 of Basic Biology III awards announced by the Independent Citizens’ Oversight Committee
(ICOC) of the California Institute for Regenerative Medicine, the state agency created by California voters to pursue the promise of stem cells in science and medicine. [University of California, San Diego Press Release]

NIH Grant Launches Center for Reproductive and Stem Cell Biology
The Center for Reproductive and Stem Cell Biology has been tapped to become one of a select group of National Institutes of Health (NIH)
research centers, as a part of a grant of about $10 million awarded earlier. [Stanford University School of Medicine Press Release]

Stanford Creates First PhD Program in Stem Cell Science
Stanford University’s Faculty Senate approved the creation of what officials believe is the first stem cell science PhD program in the nation
and, perhaps, the world. The new doctoral program in stem cell biology and regenerative medicine is also the first interdisciplinary doctoral program created by the School of Medicine in recent years. [Stanford University School of Medicine Press Release]

POLICY NEWS
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
EVENTS
NEW ESH-ICMLF 13th International Conference: Chronic Myeloid Leukemia – Biology and Therapy
September 22-25, 2011
Estoril, Portugal

Visit our events page to see a complete list of events in the cord blood community.
JOB OPPORTUNITIES

Implementation Coordinator – Maternity Leave Contract (STEMSOFT Software Inc.)

Lab Technologist – Human Embryonic and Induced Pluripotent Stem Cells (STEMCELL Technologies)

Quality Assurance Manager – Program in Children’s Regenerative Medicine (The University of Texas Medical School at Houston)

Supervisor Cell Therapy Laboratory – Cord Blood Bank (The University of Texas MD Anderson Cancer Center)

Supervisor Cell Therapy Lab (The University of Texas MD Anderson Cancer Center)

Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Jobs are categorized regionally: United States, Canada, Europe, Asia Pacific

Visit here to post your career opportunities.

Have we missed an important article or publication in Cord Blood News? Click here to submit!

Comments or Suggestions? Email [email protected] with your feedback.

Learn more about Cord Blood News: Archives | Events | Contact Us